August 3rd, 2017 (BOSTON, MA) Aldatu Biosciences, a biotechnology company developing innovative diagnostics for complex infectious diseases on its PANDAA qDx platform, today announced the expansion of its Scientific and Business Advisory Board with the additions of Michael (Mike) Henry, MBA and Marta Fernández Suárez, Ph.D. Mike Henry has over 20 years of senior leadership experience in biotechnology business development …